Answer
The estimated half-life of nitisinone in patients with hereditary tyrosinaemia type 1 is 52.1 hours, based on a population pharmacokinetic analysis of 207 patients.
Sources for this answer
- Orfadin 4mg/ml Oral SuspensionSwedish Orphan Biovitrum Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 10Document updated
Sources checked